Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Merck KGaA divests allergy business to Dermapharm

Merck KGaA divests allergy business to Dermapharm The sum of the agreement remains undisclosed. Germany’s Merck KGaA has agreed to sell its allergy business – Allergopharma – to Dermapharm for an undisclosed sum. ... The value of Allergopharma was disclosed, however, with Merck revealing that in

BMS unveils long-term results for Opdivo in kidney cancer

BMS unveils long-term results for Opdivo in kidney cancer RCC. BMS is facing increasing competition in kidney cancer, however, from the likes of other combination regimens such as Merck &Co/Pfizer’s Keytruda plus Inlyta and Pfizer/Merck KGaA’s ... Merck’s drug is also already widely prescribed by

NICE turns down Keytruda/Inlyta combo for kidney cancer

NICE turns down Keytruda/Inlyta combo for kidney cancer Cost-effectiveness agency says the long-term benefit is uncertain. NICE has said that the recently-approved combination of Merck &Co/MSD’s Keytruda with Pfizer’s Inlyta shouldn’t be ... Keytruda/Inlyta is however also competing in Europe with the

Novartis pulls ahead of Merck in MET-positive lung cancer race

Novartis pulls ahead of Merck in MET-positive lung cancer race The start of the review puts Novartis in a position to bring a drug for MET-mutated NSCLC to market ahead of Merck KGaA, which is developing a rival MET inhibitor ... It was also effective in brain metastases, according to Merck, which hasn’t yet filed

Pfizer signs $507m cancer deal with Effector Therapeutics

Pfizer signs $507m cancer deal with Effector Therapeutics It has already signed previous collaboration deals with Pfizer and Merck KGaA to study tomivosertib in combination with Bavencio (avelumab) and with Merck &Co to evaluate the candidate with blockbuster

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Guide
How to embrace behavioural science principles in healthcare MR...
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...